The integration of multiple HIV/AIDS projects into a coordinated national programme in China
Zunyou Wu a, Yu Wang b, Yurong Mao a, Sheena G Sullivan a, Naomi Juniper a & Marc Bulterys c
a. National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, 155 Changbai Road, Changping District, Beijing, 102206, China.
b. Chinese Center for Disease Control and Prevention, Beijing, China.
c. The Global AIDS Program (GAP) in China, United States Centers for Disease Control and Prevention, Beijing, China.
Correspondence to Zunyou Wu (e-mail: firstname.lastname@example.org).
(Submitted: 05 September 2010 – Revised version received: 14 January 2011 – Accepted: 14 January 2011 – Published online: 01 February 2011.)
Bulletin of the World Health Organization 2011;89:227-233. doi: 10.2471/BLT.10.082552
The HIV/AIDS epidemic continues to spread and disproportionately affects people in developing countries where resources are most limited.1,2 Although recipient countries are consulted, the focus of external foreign HIV/AIDS projects is mainly determined by donors. When there are multiple donors, coordination and integration become crucial to ensure resources are used effectively and efficiently.
China, a large developing country, has experienced a rapid increase in HIV/AIDS prevalence.3,4 HIV was first reported in China in 1985 and by 1998 the virus had spread to all 31 provinces of the mainland.5 By the end of 2008, 87% of China’s 2868 counties had reported HIV/AIDS cases, including 43 which reported more than 1000 cases and five which reported more than 5000 cases.6 However, the overall HIV prevalence in China remains low.7,8
The epidemic was first reported among injecting drug users9 and was initially limited to this group.5 Later, an outbreak was reported among former plasma donors,10–12 then in other high-risk groups.5,6,13 Generalized epidemics – as indicated by an HIV prevalence of > 1% among women attending antenatal clinics – now exist in Henan, Sichuan, Xinjiang and Yunnan. Thus, the response has had to adapt and respond to the evolving epidemic, a process which has been facilitated by the many generous grants from external donors.14
Until 2003, China’s HIV/AIDS programmes were mainly supported by international donors (Fig. 1).3,14 Programmes included bilateral support from countries such as Australia, the United Kingdom of Great Britain and Northern Ireland and the United States of America,15,16 various United Nations agencies and multilateral agencies, especially the Global Fund to Fight AIDS Tuberculosis and Malaria (Global Fund), which has contributed more than US$ 400 million, making it the single largest donor for HIV/AIDS-related programmes in China.17 Support has also been forthcoming from private foundations, such as the William J Clinton Foundation, the Merck Co. Foundation18 and the Bill & Melinda Gates Foundation (Gates Foundation).19 These bilateral, multilateral and private partnerships have had a major impact on the direction and success of the HIV/AIDS response in China.14 For example, one of the earliest projects, funded by the World Health Organization (WHO), set the ground work for establishing HIV surveillance in China.20 Funding from The World Bank has promoted the roles of policy advocacy, capacity building, surveillance, primary prevention and mobilization of nongovernmental organizations to participate in HIV/AIDS programmes;21 programmes funded by the United Kingdom Department for International Development (DFID)22,23 and the Australian Agency for International Development (AusAID) contributed to increasing the government’s capacity to work with HIV high-risk groups and promoted harm reduction for drug users;16 funding from the United States Global AIDS Program (GAP) has played a significant role in improving the effectiveness of national and provincial programmes and in piloting innovative technical approaches; and funding from the United States National Institutes of Health has strengthened the scientific capacity of the AIDS response.14
Fig. 1. Major international and domestic HIV/AIDS projects in China, 1993–2009
Observing these significant foreign investments in the HIV/AIDS response, and with pressure from the international community, the Chinese government increased its contribution from 100 million yuan (approximately US$ 15 million) in 2001, to 810 million yuan (US$ 100 million) in 2004, and to 1.6 billion (US$ 239 million) in 2010.3,24,25 In 2003, the government launched the China Comprehensive AIDS Response (China CARES) programme to improve treatment and care for people with HIV/AIDS.24,26 A significant catalyst in this process was the outbreak of severe acute respiratory syndrome (SARS) in 2003 which prompted China to change its public health strategy,27 making HIV/AIDS a priority infectious disease. In addition, China’s economic growth in recent years meant that the government had the financial means to support budget increases for the HIV/AIDS programme. To respond more effectively to the epidemic, a second five-year action plan was issued with quantitatively-measurable targets and increased funding.28 China now funds more than 80% of its HIV/AIDS programme.29
Lack of coordination
Given the involvement of so many different organizations, coordination has become a major challenge. Efforts were made by each large HIV/AIDS project during the planning stages to avoid overlap in the selection of project sites and target groups. For example, Rounds 3, 4 and 5 of the Global Fund were carefully designed to avoid geographic and programmatic overlap. However, problems began to emerge during the implementation of various programmes. Funding was typically allocated to locations reporting the most severe epidemics, which led to project overlap. For example, in 2005, the Tianshan District in Urumqi City had five HIV/AIDS projects separately funded by China CARES, The World Bank, AusAID, DFID and GAP. Local AIDS authorities became inundated with project-related work, especially report writing. Staff coordinating multiple projects or projects which required separate reports for every activity funded were left with limited time to actually carry out the project activities. Moreover, the quality of delivery of project activities was compromised because they relied on these overstretched staff.
Another issue that began to emerge was the problem of unspent or misused funds when several projects were concentrated in one location. Capacity to adequately use funds was limited due to a shortage of capable personnel. At the same time, funds went to high-incidence areas, resulting in insufficient funding for low-incidence areas to carry out basic HIV/AIDS activities, such as establishing HIV testing facilities and laboratory support. Not only was this counter-productive, it may have contributed to the silent rise of HIV infections in areas which unwittingly transitioned from low- to medium- or high-prevalence areas.
Inconsistency in data collection, measurement and reliability was another concern. Some projects collected similar information from patients, such as sociodemographic information, risk behaviour history and treatment follow-up, but this information could not be shared or compared because of variations in data elements, coding schemes and definitions among projects. In addition, projects only had data pertaining to their own project and lacked a comprehensive picture of the overall situation, limiting their use for government-led planning. For example, in 2005, data compiled by the Global Fund Round 3 AIDS Project included far fewer HIV/AIDS cases and patients on antiretroviral treatment than were known to the national HIV/AIDS information system.
The urgency of integrating all HIV/AIDS projects into one national programme became increasingly obvious for an effective response to the epidemic in China.
Unifying data collection
The first step of integration was to standardize and unify HIV/AIDS data collection and specify common key indicators to measure implementation and effectiveness. The second five-year action plan was used to guide this process.28 Worldwide there were many different monitoring and evaluation indicators sets, including United Nations General Assembly Special Session (UNGASS) report indicators,30 the Global Fund’s AIDS indicators31 and the World Health Organization’s HIV/AIDS indicators.32 All possible indicators were assembled, reviewed and analysed. Indicators commonly used across all systems were selected and specified for the Chinese national monitoring and evaluation system, which now contains just 19 key indicators.33
Before unification and standardization, there were 56 forms with 225 variables in use for data collection. These forms were used by multiple programmes including HIV/AIDS case reporting, HIV sentinel surveillance and behavioural surveillance, voluntary counselling and testing, outreach for condom promotion, needle exchange, methadone maintenance treatment, antiretroviral therapy (ART), China CARES and the Global Fund’s AIDS Projects. All data collection forms were assembled, reviewed and revised against the key indicators developed in the national monitoring and evaluation system, and then comprehensively pilot tested. After unification and standardization, this was reduced to 25 forms and 19 indicators.34,35
An online comprehensive HIV/AIDS data system was developed and became operational on 1 January 2008. The system provides data on newly identified HIV infections, drug users in the methadone programme and HIV/AIDS patients in the free ART programme. Data are entered into this system from all HIV/AIDS projects operating in China and are provided as needed to those programmes for monitoring of implementation and assessment of project impact.34 This process has significantly reduced the workload of project staff in project sites, as well as permitted a much clearer picture of the country’s progress in its HIV/AIDS response. Since 1 January 2008, monthly, seasonal and annual statistical reports on the implementation of the national HIV/AIDS programme have been generated based on this system.
Platforms for integration
Six major national HIV/AIDS programmes have been developed, and these allow for easy integration of major foreign HIV/AIDS projects into the national programme.34 The Chinese government is the major funder of all these programmes; however, all international and domestic HIV/AIDS projects containing relevant components to strengthen these programmes have been integrated.
This programme monitors changes and trends in the HIV/AIDS epidemic.6,20,34,36 In 2009 there were 1318 surveillance sites. The sentinel surveillance was reviewed and expanded to 1888 sites in 2010.37 Foreign assistance (e.g. from GAP) has helped strengthen the capacity of implementation of surveillance at both national and local levels, by providing training, assistance in supervision and drafting reports.
There are now more than 8000 laboratories able to provide HIV antibody screening testing, 370 laboratories able to provide HIV Western blot confirmatory testing and CD4+ T-cell counts, and approximately 30 laboratories able to provide HIV viral load testing.38 International assistance for the laboratory network (e.g. from GAP) has mainly focused on personnel training, quality assurance for CD4 counts and viral load, and supporting operational research on new technology applications such as the immunoglobin G-capture BED enzyme immunoassay,39,40 early infant diagnosis41 and HIV drug-resistance testing.42
These include the prevention programmes for sex workers and men who have sex with men, methadone and needle exchange programmes for drug users, and the programme for the prevention of mother-to-child transmission.3,34,43,44 Foreign aid focuses on high-risk groups, e.g. the Gates Foundation project focuses on out-reach HIV testing among men who have sex with men; AusAID projects focus on needle exchange in Guangxi, Yunnan and Xinjiang.
Free ART programme
Free ART was initiated in 2003 and now provides treatment for more than 80 000 AIDS patients.45 Major external projects supporting treatment include the Global Fund Round 3, which provided funding for the purchase of antiretroviral drugs and for training health workers; the Clinton Foundation AIDS Project, which supported paediatric treatment46; and GAP, which provided training for rural health-care providers and technical support.
Testing and counselling
Initially established as a voluntary counselling and testing programme in 2003, this programme was expanded to provider-initiated testing and counselling in 2005 to encourage routine HIV testing of high-risk groups.34 Most international AIDS projects have components of HIV testing and these have been integrated into the national programme.
The major objective is to prevent transmission from people living with HIV to their sexual and drug-using partners, and to provide good medical care and social support to those already infected.34 This has been a major goal of the China CARES programme and the Global Fund Round 3. Support from GAP and the Gates Foundation have played a role in improving available services.
Planning and budgeting
Adequate project planning is crucial for the successful integration of foreign projects into one national programme. The second five-year action plan is used as a framework for planning foreign-funded HIV/AIDS projects. Understanding the coverage of all existing HIV/AIDS projects is important to identify gaps in the national response and to direct the planning of new projects so that they can be well integrated with existing projects.
Ensuring budget integration of funding sources is also crucial to ensure adequate funding so planned activities can be fully implemented and are complementary to the national programme. A typical example for budget integration is the China national harm reduction programme with the use of government funds for the purchase of equipment, methadone and personnel training, and Global Fund Round 4 monies for methadone treatment and needle exchange programmes.
Monitoring and evaluation
Reports derived from project-specific monitoring, supervision and evaluation activities are relevant to the project implementation team and the funding organizations. However, they only present one aspect of the HIV/AIDS epidemic and response and can sometimes create confusion. Since 2007 China has conducted these activities according to location rather than project. Specifically, three levels of monitoring, supervision and evaluation are used, namely the policy-level, comprehensive technical-level, and specialized technical- and project- level.
Policy-level monitoring, supervision and evaluation is done by a group of high-level government officials led by a vice minister from the State Council AIDS Working Committee and several AIDS experts as consultants. They focus on policy implementation and promote multisectoral responses and solve political and policy issues. Usually, a leader from each major HIV/AIDS project is invited to participate.
The comprehensive technical level involves a group of HIV/AIDS experts from the fields of epidemiology, laboratory, prevention and treatment, accompanied by HIV/AIDS project officers. The experts are usually selected from the Chinese Ministry of Health HIV/AIDS Expert Panel and from technical divisions of the National Center for AIDS/STD Control and Prevention. This team assesses the epidemic situation, prevention, treatment and care programme implementation funded by both domestic and foreign sources.
The specialized technical- and project-level includes epidemiology, prevention, and treatment and care services. Examples of activities included at this level are supervision of sentinel surveillance data quality, problem solving in reaching greater numbers of drug users by extending services from methadone clinics to community health clinics, and understanding issues with compliance to ART and management of opportunistic infections.
The integration of monitoring, supervision and evaluation has greatly reduced the workload for both central and local levels. For example, the average number of person-visits to one province in a year had reduced from 20–25 visits to 11–14 visits after integration.
Impact of integration
The reactions to the integration have been positive from donors. First, the country offices in China for the Joint United Nations Programme on HIV/AIDS (UNAIDS) and the World Health Organization have actively supported and participated in the integration process. The Global Fund, the largest donor, is also a great supporter. When its Round 3 AIDS project ended in 2008, the Global Fund agreed to merge its ongoing Round 4, 5 and 6 projects and the recently approved Round 8 project into a single project that is fully integrated into China’s national AIDS programme. Bilateral HIV/AIDS projects, including GAP and DFID, were already integrated into the national programmes and there was support from private foundations, such as the Gates Foundation and the William J Clinton Foundation. Integration has greatly facilitated implementation of the national HIV/AIDS programme.34,35 For example, the number of identified and reported HIV-infected men who have sex with men increased by 83% between 2007 and 2009 in the 15 provincial capitals supported by the Gates Foundation project, but only increased by 42% in other provincial capitals.47
The integration has brought great benefits for the Chinese health system. First, it has reduced the workload for local health agencies implementing HIV/AIDS activities. Previously health staff working at project sites had to complete up to 123 different forms for multiple projects. This has been reduced to 25 electronic forms. Second, the integration has been able to leverage resources for overall health care in local communities. For example, blood specimens collected for HIV testing at surveillance sites and methadone clinics are also used for testing syphilis and hepatitis C; prevention of mother-to-child transmission of HIV has been extended to prevention of congenital syphilis and hepatitis B. Ensuring an efficient and economically accessible rural health system is one of China’s most pressing challenges.48
Limitations of integration
Several challenges were encountered during the integration of programmes. First, additional time and effort is required for coordinating planning, budgeting, implementation and evaluation of multiple projects. Although some staff reported the extra work, their complaints dissipated when they were able to see that time and effort was saved at later stages of project management.
Second, integration may make the impact of a single project “invisible” if it does not have specific features. For example, GAP has almost completely integrated its work into the national AIDS programme so its impacts are difficult to disentangle from the overall AIDS programme. Conversely, the Gates Foundation has focused on projects for men who have sex with men over and above those routinely performed by government agencies; significant improvements in HIV testing and follow-up services for this marginalized group can be attributed to this project.
The process of integrating all HIV/AIDS projects into one national AIDS programme in China is a prime example of the “Three Ones” principles advocated by UNAIDS.49 Integration started with creating unified and standardized data collection forms and resulted in the establishment of a national comprehensive online HIV/AIDS data system. Six national programmes serve as platforms for integration of foreign projects. The integration has brought many benefits for both the Chinese government and for external project funders. The model of integration recounted here may serve as a useful model for other countries.
We thank Chin-Yih Ou and RJ Simonds for their helpful comments during the preparation of this manuscript.
Zunyou Wu is the director of the National Centre for AIDS/STD Control and Prevention in the Chinese Center for Disease Control and Prevention. Yu Wang is the director of the Chinese Center for Disease Control and Prevention. Both have been directly involved in the development and scale-up of the national AIDS programme.
Preparation of the paper was partly supported by grant # 5U2RTW006918-07 from the United States National Institutes of Health which includes funding from the Fogarty International Center and the National Institute on Drug Abuse. SGS was supported by a travel grant from the UCLA Center for Global and Immigrant Health.
- AIDS epidemic update, December 2009. Geneva: Joint United Nations Programme on HIV/AIDS; 2009. Available from: http://www.unaids.org/en/media/unaids/contentassets/dataimport/pub/report/2009/jc1700_epi_update_2009_en.pdf [accessed 20 January 2011].
- Towards universal access: Scaling up priority HIV/AIDS interventions in the health sector: progress report 2009. Geneva: World Health Organization; 2009. Available from: http://www.who.int/hiv/pub/2009progressreport/en/ [accessed 20 January 2011].
- Wu Z, Sullivan SG, Wang Y, Rotheram-Borus MJ, Detels R. Evolution of China’s response to HIV/AIDS. Lancet 2007; 369: 679-90 doi: 10.1016/S0140-6736(07)60315-8 pmid: 17321313.
- Cui Y, Liau A, Wu ZY. An overview of the history of epidemic of and response to HIV/AIDS in China: achievements and challenges. Chin Med J (Engl) 2009; 122: 2251-7 pmid: 20079122.
- Wu Z, Rou K, Cui H. The HIV/AIDS epidemic in China: history, current strategies and future challenges. AIDS Educ Prev 2004; 16: 7-17 doi: 10.1521/aeap.188.8.131.52.35521 pmid: 15262561.
- 2008 HIV/AIDS statistics in China. Beijing: Chinese Center for Disease Control and Prevention; 2009.
- The estimation of HIV/AIDS in China in 2009. Beijing: Ministry of Health; 2010.
- Wang N, Wang L, Wu Z, Guo W, Sun X, Poundstone K, et al., National Expert Group on HIV/AIDS Estimation, et al. Estimating the number of people living with HIV/AIDS in China: 2003–09. Int J Epidemiol 2010; 39: ii21-8 doi: 10.1093/ije/dyq209 pmid: 21113033.
- Ma Y, Li ZZ, Zhang KX. Identification of HIV infection among drug users in China. Zhonghua Liu Xing Bing Xue Za Zhi 1990; 11: 184-5.
- Wu Z, Liu Z, Detels R. HIV-1 infection in commercial plasma donors in China. Lancet 1995; 346: 61-2 doi: 10.1016/S0140-6736(95)92698-4 pmid: 7603178.
- Wu Z, Rou K, Detels R. Prevalence of HIV infection among former commercial plasma donors in rural eastern China. Health Policy Plan 2001; 16: 41-6 doi: 10.1093/heapol/16.1.41 pmid: 11238429.
- Dou Z, Chen RY, Wang Z, Ji G, Peng G, Qiao X, et al., et al. HIV-infected former plasma donors in rural Central China: from infection to survival outcomes, 1985–2008. PLoS One 2010; 5: e13737- doi: 10.1371/journal.pone.0013737 pmid: 21060835.
- State Council AIDS Working Committee Office, United Nations Theme Group on AIDS in China. A joint assessment of HIV/AIDS prevention, treatment and care in China. Beijing: Ministry of Health; 2007.
- Sun J, Liu H, Li H, Wang L, Guo H, Shan D, et al., et al. Contributions of international cooperation projects to the HIV/AIDS response in China. Int J Epidemiol 2010; 39: ii14-20 doi: 10.1093/ije/dyq208 pmid: 21113032.
- Ye L. United States CDC GAP in China. In: Wang L, editor. Epidemic and control of AIDS in China. Beijing: Beijing Press; 2006.
- The Yining city injecting drug user harm reduction program: experience gained, expansion achieved. Urumqi: Xinjiang HIV/AIDS Prevention and Care Project; 2006.
- Han M, Wei R, Hu H. Global Funds AIDS Project in China. In: Wang L, editor. Epidemic and control of AIDS in China. Beijing: Beijing Press; 2006:118-28.
- China-MSD HIV/AIDS Partnership [Merck corporate website]. Available from: http://www.merck.com/corporate-responsibility/access/access-hiv-aids/access-hiv-aids-cmap-china/home.html [accessed 20 January 2011].
- Prevention HIV in China. Seattle: Bill & Melinda Gates Foundation;2009. Available from: http://www.gatesfoundation.org/global-health/Pages/hiv-prevention-china.aspx [accessed 20 January 2011].
- Sun X, Wang N, Li D, Zheng X, Qu S, Wang L, et al., et al. The development of HIV/AIDS surveillance in China. AIDS 2007; 21: S33-8 doi: 10.1097/01.aids.0000304694.54884.06 pmid: 18172389.
- Duan M. The World Bank 9th Health Loan Project on AIDS in China. In: Wang L, editor. Epidemic and control of AIDS in China. Beijing: Beijing Press; 2006:118-28.
- China-UK HIV/AIDS Prevention and Care Project. Best-practice case studies. Beijing: United Kingdom Department for International Development; 2004.
- Zhang Y. UK-China AIDS Project. In: Wang L, editor. Epidemic and control of AIDS in China. Beijing: Beijing Press; 2006:118-28.
- State Council AIDS Working Committee Office, United Nations Theme Group on AIDS in China. A joint assessment of HIV/AIDS prevention, treatment and care in China. Beijing: Ministry of Health; 2004.
- Wen JB. Delivering results towards our shared commitments. In: United Nations Summit on the Millennium Development Goals, New York, 22 September, 2010. Beijing: Ministry of Foreign Affairs; 2010. Available from: http://www.fmprc.gov.cn/eng/topics/wenjibaochuxi65jieUNdh/t761316.htm [accessed 20 January 2011].
- Han M, Chen Q, Hao Y, Hu Y, Wang D, Gao Y, et al., et al. Design and implementation of a China comprehensive AIDS response programme (China CARES), 2003–08. Int J Epidemiol 2010; 39: ii47-55 doi: 10.1093/ije/dyq212 pmid: 21113037.
- Liu Y. China’s public health-care system: facing the challenges. Bull World Health Organ 2004; 82: 532-8 pmid: 15500285.
- China's Action Plan for Reducing and Preventing the Spread of HIV/AIDS. (2006 - 2010), State Council Document (2006) no. 13. Beijing: Office of the State Council; 2006.
- China 2010 UNGASS Country Progress Report (2008-2009). Beijing; Ministry of Health; 2010.
- Monitoring the Declaration of Commitment on HIV/AIDS: guidelines on constructions of core indicators. Geneva; Joint United Nations Programme on HIV/AIDS; 2005.
- Monitoring and evaluation toolkit. Geneva: The Global Fund to Fight AIDS, Tuberculosis and Malaria; 2009.
- Monitoring and reporting on the health sector's response towards universal access to HIV/AIDS treatment, prevention, care and support, 2007–2010. WHO framework for global monitoring and reporting. Geneva: World Health Organization; 2007.
- Chinese Center for Disease Control and Prevention. Framework for AIDS monitoring and evaluation in China. Beijing: People's Health Publishing House; 2007.
- Mao Y, Wu Z, Poundstone K, Wang C, Qin Q, Ma Y, et al., et al. Development of a unified web-based national HIV/AIDS information system in China. Int J Epidemiol 2010; 39: ii79-89 doi: 10.1093/ije/dyq213 pmid: 21113041.
- Liu Y, Wu Z, Mao Y, Rou K, Wang L, Zhang F. Quantitatively monitoring AIDS policy implementation in China. Int J Epidemiol 2010; 39: ii90-6 doi: 10.1093/ije/dyq214 pmid: 21113042.
- Wang L, Wang N, Wang L, Li D, Jia M, Gao X, et al., et al. The 2007 estimates for people at risk for and living with HIV in China: Progress and Challenges. J Acquir Immune Defic Syndr 2009; 50: 414-8 doi: 10.1097/QAI.0b013e3181958530 pmid: 19214116.
- National Center for AIDS/STD Control and Prevention. China's HIV sentinel surveillance report in 2010. Beijing: Chinese Center for Disease Control and Prevention; 2010.
- Jiang Y, Qiu M, Zhang G, Xing W, Xiao Y, Pan P, et al., et al. Quality assurance in the HIV/AIDS laboratory network of China. Int J Epidemiol 2010; 39: ii72-8 doi: 10.1093/ije/dyq224 pmid: 21113040.
- Jiang Y, Wang M, Ni M, Duan S, Wang Y, Feng J, et al., et al. HIV-1 incidence estimates using IgG-capture BED-enzyme immunoassay from surveillance sites of injection drug users in three cities of China. AIDS 2007; 21: S47-51 doi: 10.1097/01.aids.0000304696.62508.8a pmid: 18172391.
- McDougal JS, Parekh BS, Peterson ML, Branson BM, Dobbs T, Ackers M, et al., et al. Comparison of HIV type 1 incidence observed during longitudinal follow-up with incidence estimated by cross-sectional analysis using the BED capture enzyme immunoassay. AIDS Res Hum Retroviruses 2006; 22: 945-52 doi: 10.1089/aid.2006.22.945 pmid: 17067263.
- Ou CY, Yang H, Balinandi S, Sawadogo S, Shanmugam V, Tih PM, et al., et al. Identification of HIV-1 infected infants and young children using real-time RT PCR and dried blood spots from Uganda and Cameroon. J Virol Methods 2007; 144: 109-14 doi: 10.1016/j.jviromet.2007.04.003 pmid: 17553573.
- Han J, Wang L, Jiang Y, Zhang Q, Fang L, Yao J, et al., et al. Resistance mutations in HIV-1 infected pregnant women and their infants receiving antiretrovirals to prevent HIV-1 vertical transmission in China. Int J STD AIDS 2009; 20: 249-54 doi: 10.1258/ijsa.2008.008480 pmid: 19304969.
- Rou K, Sullivan SG, Liu P, Wu Z. Scaling up prevention programmes to reduce the sexual transmission of HIV in China. Int J Epidemiol 2010; 39: ii38-46 doi: 10.1093/ije/dyq211 pmid: 21113035.
- Yin W, Hao Y, Sun X, Gong X, Li F, Li J, et al., et al. Scaling up the national methadone maintenance treatment program in China: achievements and challenges. Int J Epidemiol 2010; 39: ii29-37 doi: 10.1093/ije/dyq210 pmid: 21113034.
- Zhang F, Dou Z, Ma Y, Zhao Y, Liu Z, Bulterys M, et al., et al. Five-year outcomes of the China national free antiretroviral treatment program. Ann Intern Med 2009; 151: 241-51, W-52 pmid: 19687491.
- Zhao Y, Sun X, He Y, Tang Z, Peng G, Liu A, et al., et al. Progress of the National Pediatric Free Antiretroviral Therapy program in China. AIDS Care 2010; 22: 1182-8 doi: 10.1080/09540121003615129 pmid: 20665285.
- The Bill-Melinda Gates Foundation Project Office. The China – Bill & Melinda Gates Foundation AIDS project performance report in 2009. Beijing: National Center for AIDS/STD Control and Prevention; 2010.
- Chen Z. Launch of the health-care reform plan in China. Lancet 2009; 373: 1322-4 doi: 10.1016/S0140-6736(09)60753-4 pmid: 19376436.
- The “Three Ones”. Geneva: The Joint United Nations Programme on AIDS; 2004. Available from: http://www.unaids.org/en/CountryResponses/MakingTheMoneyWork/ThreeOnes/default.asp [accessed 20 January 2011].